Group One Trading
ITOS

Group One Trading’s iTeos Therapeutics ITOS Stock Holding History

Group One Trading’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,900
Closed -$208K – 8741
2025
Q2 		$208K Buy
+20,900
New +$168K ﹤0.01% 4302
2025
Q1 		– Sell
-73,100
Closed -$561K – 7960
2024
Q4 		$561K Sell
73,100
-347,600
-83% -$2.99M ﹤0.01% 3076
2024
Q3 		$4.3M Buy
+420,700
New +$6.42M 0.01% 1115
2024
Q2 		– Sell
-53,200
Closed -$726K – 7094
2024
Q1 		$726K Buy
53,200
+22,200
+72% +$242K ﹤0.01% 2384
2023
Q4 		$339K Sell
31,000
-3,200
-9% -$31.7K ﹤0.01% 3396
2023
Q3 		$374K Buy
34,200
+24,600
+256% +$315K ﹤0.01% 3207
2023
Q2 		$127K Buy
+9,600
New +$137K ﹤0.01% 4382
2022
Q3 		– Sell
-21,700
Closed -$447K – 7851
2022
Q2 		$447K Buy
+21,700
New +$515K ﹤0.01% 3537

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's ITOS Position: Q2 2025 in Review

Group One Trading sold out of iTeos Therapeutics (ITOS) in Q2 2025, closing a stake of 12,327 shares — an estimated $99.3K sold.

Group One Trading first reported a position in ITOS in Q2 2022 and held it in 8 quarters. The position peaked at $1M in Q4 2024. 136 funds tracked by Wall St. Rank hold ITOS as of Q2 2025.

  • Group One Trading reported no remaining iTeos Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 12,327 iTeos Therapeutics shares in Q2 2025, an estimated $99.3K.
  • Group One Trading first reported a position in iTeos Therapeutics in Q2 2022 and held it in 8 quarters.
  • Group One Trading's iTeos Therapeutics position peaked at $1M in Q4 2024.
  • 136 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.